1. Home
  2. KODK vs XNCR Comparison

KODK vs XNCR Comparison

Compare KODK & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$9.86

Market Cap

1.1B

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.26

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
XNCR
Founded
1880
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
881.9M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
KODK
XNCR
Price
$9.86
$11.26
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$22.33
AVG Volume (30 Days)
1.2M
712.4K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
$4,114,000,000.00
$125,576,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.65
52 Week Low
$4.94
$6.92
52 Week High
$14.87
$18.69

Technical Indicators

Market Signals
Indicator
KODK
XNCR
Relative Strength Index (RSI) 38.49 42.24
Support Level $6.04 $11.02
Resistance Level $9.96 $13.28
Average True Range (ATR) 0.70 0.72
MACD -0.35 -0.16
Stochastic Oscillator 11.78 24.53

Price Performance

Historical Comparison
KODK
XNCR

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: